Precision Cancer Medicine PARP Inhibitor Promising Treatment for Small Cell...
The results of a recent study published in The Journal of Clinical Oncology suggest the first new therapeutic option for […] The post Precision Cancer Medicine PARP Inhibitor Promising Treatment for...
View ArticlePreparing for Surgery
CancerConnect News: You can help ensure that your cancer surgery and recovery go smoothly and that you have the best […] The post Preparing for Surgery appeared first on .
View ArticleWhat to Tell Children when Facing a Diagnosis of Cancer
If you have children in your life, you already know that they tend to be creatures of habit who rely […] The post What to Tell Children when Facing a Diagnosis of Cancer appeared first on .
View ArticleAsk the Expert: Advanced Lung Cancer
Ask the Expert with Dana-Farber Cancer Institute’s Dr. Jackman CancerConnect recently partnered with Dana-Farber Cancer Institute to provide you with […] The post Ask the Expert: Advanced Lung Cancer...
View ArticleRecent Advances in The Management of Lung Cancer
The last 12 months continue to show advances in the treatment of non-small cell lung cancer (NSCLC), once again most […] The post Recent Advances in The Management of Lung Cancer appeared first on .
View ArticleKeytruda® Active in Small Cell Lung Cancer
Recently updated findings from the phase 1b KEYNOTE-028 study investigating the use of Keytruda® (pembrolizumab) in small cell lung cancer […] The post Keytruda® Active in Small Cell Lung Cancer...
View ArticlePass It On: It’s National Lung Cancer Awareness Month
There are several types of lung cancer: non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), mesothelioma and lung […] The post Pass It On: It’s National Lung Cancer Awareness Month...
View ArticleFirst Targeted Therapy Shows Promise in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for approximately 20–25% of all lung cancers. SCLC is an aggressive and fast-growing type […] The post First Targeted Therapy Shows Promise in Small Cell Lung...
View ArticleTwo-Drug Immunotherapy Deemed Safe for Small Cell Lung Cancer Patients,...
Small cell lung cancer (SCLC) represents approximately 14 percent of all types of lung cancer. Many patients with SCLC respond […] The post Two-Drug Immunotherapy Deemed Safe for Small Cell Lung Cancer...
View ArticleLung Cancer Advances: Precision Medicine and Immunotherapy Make a Difference
Precision medicine continues to impact the lives of lung cancer patients with research into genomics and genetics leading to unprecedented […] The post Lung Cancer Advances: Precision Medicine and...
View ArticleAdvanced Squamous Cell Lung Cancer: The Lung-MAP Trial
The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current […] The post Advanced Squamous Cell Lung Cancer: The Lung-MAP Trial...
View ArticleRecent Advances in The Management of Lung Cancer
The last 12 months continue to show advances in the treatment of non-small cell lung cancer (NSCLC), once again most notably in the sector of precision treatment. Importantly advances in the treatment...
View ArticleKeytruda® Active in Small Cell Lung Cancer
Recently updated findings from the phase 1b KEYNOTE-028 study investigating the use of Keytruda® (pembrolizumab) in small cell lung cancer (SCLC) were recently presented at the 17th World Conference on...
View ArticlePass It On: It’s National Lung Cancer Awareness Month
There are several types of lung cancer: non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), mesothelioma and lung carcinoid tumors, with NSCLC and SCLC accounting for about 95% of...
View ArticleFirst Targeted Therapy Shows Promise in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for approximately 20–25% of all lung cancers. SCLC is an aggressive and fast-growing type of cancer that is very responsive to chemotherapy. However, although...
View ArticleTwo-Drug Immunotherapy Deemed Safe for Small Cell Lung Cancer Patients,...
Small cell lung cancer (SCLC) represents approximately 14 percent of all types of lung cancer. Many patients with SCLC respond to initial chemotherapy; however, they eventually relapse and develop...
View ArticleLung Cancer Advances: Precision Medicine and Immunotherapy Make a Difference
Precision medicine continues to impact the lives of lung cancer patients with research into genomics and genetics leading to unprecedented progress in improving outcomes. Tailored treatments have...
View ArticleSutent® Maintenance Therapy Found Active in Small-Cell Lung Cancer
Cancer Connect: Doctors have reported that maintenance therapy using Sutent® (sunitinib) delays the time to cancer progression and improves survival in patients with extensive-stage small-cell lung...
View Article5 Things Women Should Know about Lung Cancer
By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center 1. Smoking causes the...
View Article16th World Conference on Lung Cancer Expected to Highlight Advances in...
Today, September 6, the 16th World Conference on Lung Cancer (WCLC) begins in Denver, Colorado. The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More...
View Article
